课题基金 / 基金详情

Heisenberg-Professorship - Signal transduction in tumour development and drug resistance

Heisenberg-Professorship - Signal transduction in tumour development and drug resistance
海森堡教授席 - 肿瘤发展和耐药性中的信号转导
批准号:
440971475
负责人:
Professor Dr. Tilman Brummer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Heisenberg Grants
财政年份:
2020
资助国家:
德国
项目状态:
已结题
起止时间:
2019-12-31 至 2022-12-31

项目摘要

项目成果

Professor Dr. Tilman Brummer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The precondition for a Heisenberg Programme funding is high scientific quality and originality of the research project at international level and suitability for further qualification as a university teacher. Applicants need to meet all the requirements for appointment to a permanent professorship.The aim of this programme is to enable outstanding scientists to prepare for a scientific leadership function, and simultaneously work on further research topics. This research does not necessarily need to be planned and carried out in the form of a project.For this reason, and unlike the procedure in other funding programmes, both the abstracts of applications and final reports are not required and will therefore not be published in GEPRIS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional characterisation of dynamic BRAF signalling complexes and their modulation by tumour specific mutations and clinically relevant kinase inhibitors
  • 批准号:
    421542753
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professor Dr. Tilman Brummer
  • 依托单位:
Signal transduction in tumour development and drug resistance
Signal transduction in tumour development and drug resistance
A comprehensive and functional analysis of B-Raf signalling
海外基金